Summary
The effect of intra-articular (i-a) steroid injection on ESR and C-reactive protein (CRP) in rheumatoid arthritis (RA) was investigated. One week following injection of 1 or 2 knees there was a significant fall in ESR (p<0.0001) and CRP (p<0.01) in a cohort of 20 RA patients. The mean drop for both ESR and CRP was 46%. This effect lasted over a variable period up to 6 months. A survey of 50 published drug efficacy studies in RA revealed that, while 44 used ESR and 20 CRP as efficacy measures, 37 neither excluded nor recorded i-a steroid injections during the study. Steroid injections were excluded in 8 studies and recorded in 5, being used as an outcome measure in 2 of these. It is recommended that the frequency with which i-a injections are used in drug efficacy studies is reported and that they are avoided in the 3 months preceding an outcome measurement if ESR or CRP are being used as outcome measures.
Similar content being viewed by others
References
Owen, D.S. Aspiration and injection of joints and soft tissues. Eds: Kelley, W.N., Harris, E.D., Ruddy, S., Sledge, C.B. In: Textbook of Rheumatology. 3rd ed. Philadelphia, WB Saunders Company 1989. 621–636.
Ward, L.E., Mason, H.L. Systemic effects from hydrocortisone acetate administered intra-articularly to rheumatoid patients. J Lab Clin Med 1953, 42, 6, 961–962.
Symmons, D.P.M., Salmon, M., Farr, M., Bacon, P.A. Sulphasalazine treatment and lymphocyte function in patients with rheumatoid arthritis. J Rheumatol 1988, 15, 575–579.
Smith, M.D., Bertouch, J.V., Smith, A.M. et al. The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol 1988, 15, 229–232.
Fehlauer, C.S., Carson, C.W., Cannon, G.W. et al. Methotrexate therapy in rheumatoid arthritis: 2 year retrospective follow-up study. J Rheumatol 1989, 16, 307–312.
Guttierrez-Rodriguez, O., Starusta-Bacal, P., Guttierez-Montes, O. Treatment of refractory R.A. — the thalidomide experience. J Rheumatol 1989, 16, 158–163.
Segal, R., Caspi, D., Fishler, M., Wigler, I., Yaron, M. Short term effects of low dose methotrexate on the acute phase reaction in patients with rheumatoid arthritis. J Rheumatol 1989, 16, 914–917.
Langevity, P., Kaplinsky, N., Ehrenfeld, M., Pras, M., Intractable R.A. — treatment with combined methotrexate, azathioprine and hydroxychloroquine. Br J Rheumatol 1989, 28, 271–272.
Hanrahan, P.S., Scrivens, G.A., Russell, A.S. Prospective long term follow up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 1989, 28, 147–153.
Astbury, C., Hill, J., Bird, H.A. Cotrimoxazole in rheumatoid arthritis: a comparison with sulphapyridine. Ann Rheum Dis 1988, 47, 323–327.
Fishler, M., Caspi, D., Rosenbach, T.O. et al. Méthotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations. Ann Rheum Dis 1988, 47, 654–659.
Bird, H.A., Burkinshaw, L., Pearson, D. et al. A controlled trial of mandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women. Ann Rheum Dis 1987, 46, 237–243.
Pullar, T., Hunter, J.A., Capell, H.A. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1987, 46, 398–402.
Faure, G.C., Bene, M.C., Thomas, P., Famisier, J.N. An open trial of Thymulin in rheumatoid arthritis patients: sequential clinical and immunological follow-up. Clin Exp Rheumatol 1987, 5, 291–293.
Dawes, P.T., Sheeran, T.P., Fowler, P.D., Shadforth, M.F. Improving the response to gold or D-penicillamine by addition of sulphasalazine. A pilot study in 25 patients with rheumatoid arthritis. Clin Exp Rheumatol 1987, 5, 151–153.
Weinblatt, M.E., Trentham, D.E., Fraser, P.A. et al. Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 1988, 31, 167–175.
Kremur, J.M., Lee, J.K. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Arthritis Rheum 1988, 31, 577–584.
Marcolongo, R., Mathieu, A., Pala, R., Giordano, N., Fioravanti, A., Panyarasa, R. The efficacy and safety of auranofin in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum 1988, 31, 979–983.
Weinblatt, M.E., Coblyn, J.S., Fraser, P.A. et al. Cyclosporin, a treatment of refractory rheumatoid arthritis. Arthritis Rheum 1987, 30, 11–17.
Shipley, M.E., Bacon, P.A., Berry, H. et al. Pulsed methylprednisolone in active early rheumatoid disease: a dose ranging study. Br J Rheumatol 1988, 27, 211–214.
Szanto, E. Low-dose methotrexate treatment of rheumatoid arthritis; long-term observation of efficacy and safety. Clin Rheumatol 1989, 8, 323–30.
Hantzschel, H., Otto, W., Arnold, S. A comparison of prednisolone with azathioprine and prednisolone with intramuscular gold in rheumatoid arthritis. Clin Rheumatol 1988, 7, 181–187.
Needs, C.J., Smith, M., Boutagy, J. et al. Comparison of methylprednisolone (Ig IV) with prednisolone (Ig orally) in rheumatoid arthritis: A pharmacokinetic and clinical study. J Rheumatol 1988, 15, 224–228.
Farr, M., Kitas, G., Bacon, P.A. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium thiomalate. Clin Rheumatol 1988, 7, 242–248.
Boerbooms, A.M.Th., Jeurissen, M.E.C., Westgeest, A.A.A., Theunisse, H., van de Putte, L.B.A., Methotrexate in refractory rheumatoid arthritis. Clin Rheumatol 1988, 7, 249–256.
Dixon, J.S., Greenwood, M., Bird, H.A. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine. Clin Rheumatol 1988, 7, 262–266.
Jantti, J., Seppala, E., Vapaatalo, H., Isomaki, H. Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clin Rheumatol 1989, 8, 238–244.
Gibson, T., Emery, P., Armstrong, R.D., Crisp, A.J., Panayi, G.S. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis — a comparative study. Br J Rheumatol 1987, 26, 279–284.
Smith, M.D., Ahern, M.J., Roberts-Thomson, P.J. Pulse steroid therapy in rheumatoid arthritis: Can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? Ann Rheum Dis 1988, 47, 28–33.
Dougados, M., Awada, H., Amor, B. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients. Ann Rheum Dis 1988, 47, 127–133.
Walters, M.T., Cawley, M.I.D. Combined suppressive drug treatment in severe refractory rheumatoid disease: an analysis of the relative effects of parenteral methylprednisolone, cyclophosphamide and sodium aurothiomalate. Ann Rheum Dis 1988, 47, 924–929.
Hansen, T.M., Dickmeiss, E., Jans, H., Hansen, T.I., Ingeman-Nielsen, M., Lorenzen, I. Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis. Ann Rheum Dis 1987, 46, 290–295.
Richards, I.M., Fraser, S.M., Hunter, J.A., Capell, H.A. Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis. Ann Rheum Dis 1987, 46, 667–669.
Furst, D.E., Koehnke, R., Burmeister, L.F., Kohler, J., Cargill, I. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 1989, 16, 313–20.
Veys, E.M., Mielants, H., Verbruggen, G. et al. Interferon gamma in rheumatoid arthritis — a double blind study comparing human recombinant interferon gamma with placebo. J Rheumatol 1988, 15, 570–574.
Scott, D.L., Dawes, P.T., Tunn, E. et al. Combination therapy with gold and hydroxychloroquine in rheumatoid arthritis: a prospective, randomised, placebo controlled study. Br J Rheumatol 1989, 28, 128–133.
Nuver-Swart, I.H., van Riel, P.L.C.M., van de Putte, L.B.A., Gribnau, F.W.J. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Ann Rheum Dis 1989, 48, 389–395.
Brackertz, D., Vischer, T.L. OM-8980 in rheumatoid arthritis: a 6-month double-blind placebo controlled multicenter study. J Rheumatol 1989, 16, 19–23.
Suarez-Almazor, M.E., Fitzgerald, A., Grace, M., Russell, A.S. A randomised controlled trial of parenteral methotrexate compared with sodium aurothiomalate in the treatment of rheumatoid arthritis. J Rheumatol 1988, 15, 753–756.
Borg, G., Allander, E., Lund, B. et al. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind, placebo controlled study. J Rheumatol 1988, 15, 1747–1754.
Kolodny, A.L. Two double-blind trials of diclofenac sodium with aspirin and with naprosyn in the treatment of patients with rheumatoid arthritis. J Rheumatol 1988, 15, 1205–1211.
Atkinson, M., Germain, G., Lee, P. The efficacy and safety of sulindac (400mg vs 600mg daily) in rheumatoid arthritis. A Canadian multicentre study. J Rheumatol 1988, 15, 1001–1004.
Champion, G.D., Cairns, D.R., Bieri, D. et al. Dose response studies and long-term evaluation of auranofin in rheumatoid arthritis. J Rheumatol 1988, 15, 28–34.
Thompson, M.S., Read, J.L., Hutchings, C., Paterson, M., Harris, E.D. Jr. The cost effectiveness of auranofin: results of a randomised clinical trial. J Rheumatol 1988, 15, 35–42.
Clark, P., Tugwell, P., Bennett, K., Bombardier, C. Meta-analysis of injectable gold in rheumatoid arthritis. J Rheumatol 1989, 16, 442–447.
Morrassut, P., Goldstein, R., Cyr, M., Karsh, J., McKendry, R. Jr. Gold sodium thiomalate compared to low dose methotrexate ion the treatment of rheumatoid arthritis — a randomised double-blind 26-week trial. J Rheumatol 1989, 16, 302–306.
Vischer, T.L. A double-blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis. Ann Rheum Dis 1988, 47, 582–587.
Bijlsma, J.W.J., Huber-Bruning, O., Thijssen, J.H.H. Effect of oestrogen treatment of clinical and laboratory manifestations of rheumatoid arthritis. Ann Rheum Dis 1987, 46, 777–779.
Patrick, M., Heptinstall, S., Doherty, M. Feverfew in rheumatoid arthritis: a double-blind, placebo controlled study. Ann Rheum Dis 1989, 48, 547–549.
Pavelka, K. Jr., Pavelka, K. Sen., Peliskova, S., Vacha, J., Trnavsky, K. Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double-blind comparison of two dose regimes. Ann Rheum Dis 1989, 48, 542–546.
van Kerckhove, C., Giannini, E.H., Lovell, D.J. Temporal patterns of response to D-penicillamine, hydroxychloroquine and placebo in juvenile rheumatoid arthritis. Arthritis Rheum 1988, 31, 1253–1258.
Williams, H.J., Ward, J.R., Dahl, S.L. et al. A controlled trial comparing sulphasalazine, gold sodium thiomalate and placebo in rheumatoid arthritis. Arthritis Rheum 1988, 31, 702–713.
Koehler, B.E., Urowitz, M.B., Killinger, D.W. The systemic effects of intra-articular corticosteroid. J Rheumatol 1974, 1, 117–125.
Bull, B.S., Farr, M., Meyer, P.J., Westengard, J.C., Bacon, P.A., Stuart, J. Efficacy of tests used to monitor rheumatoid arthritis. Lancet 1989, ii, 965–967.
Anderson, J.J., Felson, D.T., Meenan, R.F., Williams, H.J. Which traditional measures should be used in rheumatoid arthritis trials. Arthritis Rheum 1989, 32, 1093–1099.
Hollander, J.L. Arthrocentesis technique and intrasynovial therapy. In: Arthritis and Allied Conditions, 10th ed., Editor: McCarty D.J., Philadelphia, Lea and Febiger, 1985, 541–553.
Gray, R.G., Tenenbaum, J., Gottlieb, N.L. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981, 10, 231–254.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taylor, H.G., Fowler, P.D., David, M.J. et al. Intra-articular steroids: Confounder of clinical trials. Clin Rheumatol 10, 38–42 (1991). https://doi.org/10.1007/BF02208031
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02208031